VMP 4145111000001102

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Tobramycin 300mg/5ml nebuliser liquid ampoules
BNF code 0501040U0AAAGAG
Virtual Therapeutic Moiety Tobramycin
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 1 Feb 2010
Previous name Tobramycin 60mg/ml nebuliser liquid 5ml ampoules
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 5.000
Unit dose form units ml
Unit dose unit of measure ampoule
Virtual Product Ingredient
Ingredient Tobramycin
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 60.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route solutionnebuliser.inhalation
Dose Form
Formulation Nebuliser liquid
Drug Route
Route Inhalation
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Munuza 300mg/5ml nebuliser solution 5ml ampoules (Aristo Pharma Ltd)
Tobi 300mg/5ml nebuliser solution 5ml ampoules (Viatris UK Healthcare Ltd)
Tobramycin 300mg/5ml nebuliser liquid ampoules (A A H Pharmaceuticals Ltd)
Tobramycin 300mg/5ml nebuliser liquid ampoules (Alliance Healthcare (Distribution) Ltd)
Tobramycin 300mg/5ml nebuliser liquid ampoules (Altan Pharma Ltd)
Tobramycin 300mg/5ml nebuliser liquid ampoules (Sun Pharma UK Ltd)
Tobramycin 300mg/5ml nebuliser liquid ampoules (Zentiva Pharma UK Ltd)
Tymbrineb 300mg/5ml nebuliser solution 5ml ampoules (Teva UK Ltd)
Virtual Medicinal Product Packs
Tobramycin 300mg/5ml nebuliser liquid ampoules 56 ampoule

dm+d data retrieved from TRUD: release NHSBSA_11.1.0_20241111000001, imported on 12th November 2024 at 03:53:04.

Feedback